Sef lucrari Dr. Iova Claudiu-Sorin

Medic primar psihiatru

Studii, cursuri si programe de pregatire: Liceul teoretic ’’Aurel Lazar’’ Oradea (1995), student la Facultatea de Medicina si Farmacie Oradea (2002), Evidence Based Medicine in Dementia and Depression in Old Age, Institutul Lundbek, Skodsborg, Danemarca (2005), Actualitati in diagnosticului dementelor si abordarea lor terapeutica, Universitatea de  Medicina si Garmacie ’Carol Davila’ Bucuresti (2005), Curs international in Psihiatria geriatrica, Asociatia Internationala de Gerontopsihiatrie si Asociatia Romana de Gerontopsihiatrie (2006), Medic rezident Psihiatrie (2009), Atestat in Managementul Serviciilor de Sanatate, Ministerul Sanatatii, Scoala Nationala de Sanatate Publica, Management si Perfectionare in Domeniul Sanitar (2010-2011), Medic specialist psihiatrie Oradea (2014), Medic primar psihiatrie (2014 - Prezent)

Activitate profesionala si didactica

2004-2009 – Medic rezident psihiatru, Spitalul Clinic Municipal ’’Dr. Gavril Curteanu’’ Oradea, sectia Psihiatrie III, in aceeasi perioada este si Preparator universitar in cadrul Universitatii din Oradea, Facultatea de Medicina si Farmacie

2009-2014 – Medic specialist psihiatru, Spitalul Clinic Municipal ’’Dr. Gavril Curteanu’’ Oradea, sectia Psihiatrie III, tot din 2009 – 2019 ocupa pozitia de asistent universitar in cadrul Universitatii din Oradea, Facultatea de Medicina si Farmacie

2014 – prezent – Medic primar psihiatru, Spitalul Clinic Judetean de Urgenta Bihor

2019 – prezent – Sef Lucrari, Universitatea din Oradea, Facultatea de Medicina si Farmacie

Activitate stiintifica

A participat ca si co-investigator la 39 de studii clinice de faza 2 si 3, printre care enumerandu se ’’a six week, randomised, Double-blind, placebo controlled, paralell group, Phase II study to determine the efficacy, tolerability and safety of low and high non-overlapping dose ranges of BL-1020 compared to placebo and risperidone in patients with acute exacerbation of schizophrenia’’,

’’A Phase III Randomized, Double-blind, Placebo and Active Comparator-controlled Clinical Trial to study the Efficacy and Safety of two doses of Lujrasidone in acutely psychotic subjects with schizophrenia’’

’’A Phase II, 6 week, multicenter, randomized double blind, placebo controlled study to evaluare the efficacy, safety and tolerability of oral OPC-34712 once daily and Aripiprazole once daily for treatment of hospitalized adult patients with acute schizophrenia’’